The US brand of patents and rights office said it will go ahead with interfered process two teams of scientists who claim to have invented a technology to edit human genes.
At stake is the right to use this technology, which could be worth hundreds of millions of euros. All this because, at the time of the patents have been posted, in force the law of “first to invent” something that changed in March 2013 to “first hand” the patent, the system most used around the world.
The process around the CRISPR, the issue of human gene technology, will last approximately eight months, says Business Insider. It is expected that in 2017, the issue of human genes may be possible.
Going to process the trial lets give a big ‘step forward’ in the use of technology.
No comments:
Post a Comment